This is part of the series of practice guidelines commissioned by the Infectious Diseases Society of America through its Practice Guidelines Committee. The purpose of this guideline is to provide assistance to clinicians in the diagnosis and treatment of community-acquired pneumonia. The targeted providers are internists and family practitioners. The targeted groups are immunocompetent adult patients. Criteria are specified for determining whether the inpatient or outpatient setting is appropriate for treatment. Differences from other guidelines written on this topic include use of laboratory criteria for diagnosis and approach to antimicrobial therapy. Panel members and consultants are experts in adult infectious diseases. The guidelines are evidence based where possible. A standard ranking system is used for the strength of the recommendations and the quality of the evidence cited in the literature reviewed. The document has been subjected to external review by peer reviewers as well as by the Practice Guidelines Committee and was approved by the IDSA Council. An executive summary and tables highlight the major recommendations. The guidelines will be listed on the IDSA home page at http://www.idsociety.org.
The second category of treatment recommendations applies NOTE. Data are from [1] .
when no etiologic diagnosis has been made and decisions on empirical antibiotic therapy are required. For this group of patients, the guideline provides multiple options because of the lack of clinical trial data that clearly identify superior regimens common causes include erroneous drug selection, dosage regiand the desire to encourage use of a broad range of drugs. The men, or diagnosis; an unusual pathogen; or dual infections or recommendations for outpatients are a macrolide, a fluoroquicomplications such as empyema. Diagnostic options in such nolone with good activity against S. pneumoniae, or doxycycases include CT imaging, bronchoscopy, and diagnostic studcline. The recommendation for hospitalized patients is a bies for alternative diagnoses. lactam (cefotaxime, ceftriaxone, or a b-lactam -b-lactamase Prevention: The recommendations also address the iminhibitor) with or without a macrolide; an equally acceptable portant role of prevention, with major emphasis on guidelines option is a fluoroquinolone with good antipneumococcal activfor proper use of influenza and S. pneumoniae vaccines. ity and established efficacy for atypical pneumonia (pneumonia due to Legionella species, C. pneumonia, or M. pneumoniae). For seriously ill patients, emphasis is placed on adequate coverage for S. pneumoniae and, less commonly, Legionella species Introduction as the major causes of lethal pneumonia. The recommendations Lower respiratory tract infections are the major cause of for empirical therapy are for a b-lactam combined with erythrodeath globally and the major cause of death due to infectious mycin, azithromycin, or a fluoroquinolone. However, the Panel diseases in the United States. Recent advances in the field recognizes that local factors such as susceptibility patterns and include the identification of new pathogens (C. pneumoniae epidemiologically important pathogens may dictate alternative and hantavirus), new methods of microbial detection (PCR), options.
and new antimicrobial agents (macrolides, b-lactam agents, Therapy with parenteral agents usually may be changed to fluoroquinolones, carbapenems, and streptogramins). Despite oral antimicrobial treatment, and patients can be discharged extensive studies, there are few medical conditions that are so from the hospital when there is evidence of a clinical response controversial in terms of management. Guidelines for manageand ability to tolerate oral medications. The recommended dument were published in 1993 by the American Thoracic Society ration of treatment for pneumococcal pneumonia is 72 hours (ATS) [1] , the British Thoracic Society [2] , and the Canadian after the patient becomes afebrile. Most other forms of pneumoInfectious Disease Society [3] . The present guidelines represent nia caused by bacterial pathogens are treated for 1 -2 weeks recommendations of the Infectious Diseases Society of after patients become afebrile. Atypical pneumonia is usually America (IDSA). In contrast to prior guidelines, these are intreated for 10 -21 days.
tended to reflect updated information, more-extensive recomResponse: Failure to respond is ascribed to multiple factors, mendations in selected areas, and an evolution of opinion. but most commonly represents inadequate host defense; less These therapeutic guidelines are restricted to community-acquired pneumonia (CAP) in immunocompetent adults. Recommendations are given alphabetical ranking to reflect their strength and a Roman numeral ranking to reflect the qualCategory Definition ity of supporting evidence (tables 1 and 2). This is customary for quality standards from the IDSA [4] . It should be acknowl- [12, 18] has also been shown. Previous pneumonia also appears to be a risk factor for death [19] . Clinical Magnitude settings that are associated with higher mortality rates are the presence of infections due to gram-negative bacilli or Staphylo-CAP is commonly defined as an acute infection of the pulmonary parenchyma that is associated with at least some sympcoccus aureus, postobstructive pneumonia, or aspiration pneumonia [8, 14] . High alcohol intake has been associated with toms of acute infection and is accompanied by the presence of an acute infiltrate on a chest radiograph or auscultatory findings an increased incidence of pneumonia [10, 20] .
Investigators from the Pneumonia Patient Outcomes Reconsistent with pneumonia (such as altered breath sounds and/or localized rales) and occurs in a patient who is not hospisearch Team (PORT) have developed a prediction rule that stratifies patients into five classes by using a cumulative point talized or residing in a long-term-care facility for §14 days before the onset of symptoms. Several symptoms of acute lower system based on 19 variables (figure 1) [9] . The rule was validated with retrospective analysis of 38,039 inpatients, respiratory tract infection (in most studies at least two) may be present, including fever or hypothermia, rigors, sweats, new which showed a direct correlation between class and mortality (table 3) . On the basis of these observations, the authors concough with or without sputum production or change in the color of respiratory secretions in a patient with chronic cough, cluded that their prediction rule identifies patients with CAP who are at risk for death and other adverse outcomes. The chest discomfort, or the onset of dyspnea. Most patients also have nonspecific symptoms such as fatigue, myalgias, abdomiauthors further suggest that the prognosis is sufficiently good in categories 1 -3 to consider outpatient management, or outpanal pain, anorexia, and headache.
Pneumonia is the sixth most common cause of death in the tient management for categories 1 and 2 with a brief observational hospital stay for category 3; patients in categories 4 and United States. Between 1979 and 1994, the overall death rates associated with pneumonia and influenza increased by 59% 5 would undergo traditional hospitalization. The Panel endorses the findings of the PORT studies as valid predictors for mortal-(on the basis of discharge diagnostic codes) in the United States [5] . Much of this increase is attributable to a greater proportion ity as well as the use of these observations as a rational foundation for decisions regarding hospitalization. Nevertheless, there of persons §65 years of age; however, age-adjusted rates also increased by 22%, suggesting that other factors may also have are multiple other factors to consider in the decision about site of care, including compliance and quality of home support contributed to a change in the epidemiology of pneumonia. These factors include the fact that a greater proportion of the [21] . It should be emphasized that the observations in the PORT study were validated as predictors of mortality and not as a population has underlying medical conditions, placing such persons at increased risk of respiratory infection. method for triaging patients; the authors also emphasize that the prognostic score should not supercede clinical judgement Annually, 2 -3 million cases of CAP result in Ç10 million physician visits, 500,000 hospitalizations, and 45,000 deaths in the decision to hospitalize [8, 21] . in the United States [6, 7] . The incidence of CAP requiring hospitalization is estimated to be 258 cases per 100,000 popula-
Role of Specific Pathogens in CAP
tion and 962 cases per 100,000 persons §65 years of age [7] . While mortality has ranged from 2% to 30% among hospitalProspective studies for evaluating the causes of CAP in adults have failed to identify the cause of 40% -60% of cases ized patients in a variety of studies, the average rate is Ç14% [8] . Mortality is estimated to be õ1% for patients who are not of CAP, and two or more etiologies have been identified in 2% -5% of cases [2, 7, 22 -25] . The most common etiologic hospitalized [8, 9] . The incidence of CAP is highest in the winter months. agent identified in virtually all studies of CAP is Streptococcus pneumoniae, and this agent accounts for approximately twothirds of all cases of bacteremic pneumonia [8] . Other patho-
Risk Factors for Mortality
gens implicated less frequently include Haemophilus influenzae (most isolates of which are other than type B), Mycoplasma Risk factors for a lethal outcome from pneumonia were well defined in the pre-penicillin era; studies in adults showed a pneumoniae, Chlamydia pneumoniae, S. aureus, Streptococcus pyogenes, Neisseria meningitidis, Moraxella catarrhalis, Klebdirect correlation with age, the presence of leukocytosis, bacteremic vs. nonbacteremic cases, extent of quantitative bactersiella pneumoniae and other gram-negative rods, Legionella species, influenza virus (depending on the time of year), respiemia, extent of radiographic changes, and extent of alcohol consumption [10] . More-recent studies have continued to show ratory syncytial virus, adenovirus, parainfluenza virus, and other microbes. The frequency of other etiologies, e.g., Chlathat most of these clinical features, including age [11, 12] and alcoholism [2, 13] are risk factors; a contributing role for mydia psittaci (psittacosis), Coxiella burnettii (Q fever), Francisella tularensis (tularemia), and endemic fungi (histoplasmomultiple associated conditions such as active malignancies [8, 9, 14, 15] , immunosuppression [11, 14 -16] , neurological dissis, blastomycosis, and coccidioidomycosis), is dependent on specific local epidemiological factors. ease [8, 9, 16, 17] , congestive heart failure [8, 16, 17] , and Prediction model for identification of patient risk for persons with community-acquired pneumonia. This model may be used to help guide the initial decision on site of care; however, its use may not be appropriate for all patients with this illness and therefore should be applied in conjunction with physician judgement. Reprinted from [9] .
Comparisons of the relative frequency of each of the etiolococcal infections. Thus, the relative contribution of many causes to the incidence of CAP is undoubtedly either exaggergies of pneumonia are hampered by the varying levels of sensitivity and specificity of the tests for each of the pathogens that ated or underestimated, depending on the sensitivity and specificity of tests used in each of the studies. these tests detect; for example, in some studies, tests used for legionella infections provide a much higher degree of sensitivity, and possibly, specificity, than that of tests used for pneumo-
Etiology-Specific Diagnoses and the Clinical Setting
No convincing association has been demonstrated between individual symptoms, physical findings or laboratory test re- Legionnaires' disease from the other patients [25] . A similar changes in relevant environmental conditions. For example, the incidence of Legionnaires' disease is dependent on the presence type of system has been devised for identifying patients with hantavirus pulmonary syndrome (HPS) [26] . If validated, such of pathogenic Legionella species in water, amplification of the bacteria in reservoirs with the ideal nutritional milieu, use of scoring systems may be useful for identifying patients who should undergo specific diagnostic tests (which are too expenaerosol-producing devices that can spread contaminated water via aerosol droplets, ideal meteorological conditions for transsive for routine use in all patients with CAP) and should be treated empirically with specific antimicrobial drugs pending porting aerosols to susceptible hosts, and the presence of susceptible hosts. Variations in any of these variables would likely the test results.
Although not absolute, certain pathogens cause pneumonia lead to variations in incidence. Likewise, increasing rainfall with associated increases in the rodent population was hypothemore commonly among persons with specific risk factors. For instance, pneumococcal pneumonia is classically a disease of sized to be the basis for the epidemic of hantavirus pulmonary syndrome in the southwestern United States in 1993 [34] . the elderly and patients with a variety of medical conditions, including chronic cardiovascular disease, asplenia, chronic obstructive pulmonary disease (COPD), immunoglobulin defiDiagnostic Evaluation ciency, hematologic malignancy, and HIV infection. S. pneumoniae is second only to P. carinii as the most common Pneumonia should be suspected in patients with newly acquired lower respiratory symptoms (cough, sputum producidentifiable cause of acute pneumonia in patients with AIDS [27 -29] . Legionella is an opportunistic pathogen -Legiontion, and/or dyspnea), especially if these symptoms are accompanied by fever, altered breath sounds, and rales. It is naires' disease is rare among healthy young children and young adults. It is an important cause of pneumonia in organ transplant recognized that there must be a balance between reasonable diagnostic procedures and empirical therapy. The importance recipients and in patients with renal failure and occurs with increased frequency in patients with chronic lung disease, those of establishing the diagnosis of pneumonia and its cause is heightened with the increasing concern for overuse of antibiwho smoke, and, possibly, in those with AIDS [30] . While it has historically been believed that M. pneumoniae primarily otics. involves children and young adults, recent evidence suggests that this organism causes pneumonia among healthy adults of Chest Radiography any age [7] .
There are seasonal differences in the incidence of many of The diagnosis of CAP requires a combination of clinical and laboratory (including microbiological) data. The differential the causes of CAP. Pneumonias due to S. pneumoniae, H. influenzae, and influenza virus occur predominantly in the diagnosis of lower respiratory tract symptoms is extensive and includes upper and lower respiratory tract infections as well as winter months, whereas C. pneumoniae appears to cause pneumonias year round. While the prevalence of outbreaks of Lenoninfectious causes (i.e., reactive airways disease, atelectasis, congestive heart failure, bronchiolitis obliterans with organizgionnaires' disease is highest in the summer, sporadic cases of Legionnaires' disease occur with similar frequency during all ing pneumonia [BOOP], vasculitis, pulmonary embolism, and pulmonary malignancy). Most upper respiratory tract infections seasons [7, 30] . Some studies suggest that there is no seasonal variation of mycoplasma infection; however, other data suggest and acute bronchitis are of viral origin, do not require antimicrobial therapy, and are the source of great antibiotic abuse that the incidence is greatest in the fall and winter months [31] .
There are other temporal variations in the incidence of some [35] . By contrast, antimicrobial therapy is usually indicated for pneumonia, and a chest radiograph is usually necessary causes of pneumonia. The frequency and severity of influenza vary as a result of antigenic drift and occasionally as a result to establish the diagnosis of pneumonia. The radiograph is occasionally useful for determining the etiologic diagnosis and of antigenic shift. For less clear reasons, increases in the incidence of mycoplasma infections occur every 3 -6 years [31, the prognosis and for detecting alternative diagnoses or associated conditions. In a time of limited resources, it may be attrac-32]. Year-to-year variations may also occur with pneumococcal pneumonia. A variety of recent studies have found that the tive to treat patients for CAP on the basis of presenting manifestations, without radiographic confirmation. However, this incidence of pneumococcal bacteremia may be increasing [33] .
Little is known about geographic differences in the incidence approach should be discouraged, given the cost and potential dangers of antimicrobial abuse in terms of side effects and of pneumonia. Passive surveillance data from the Centers for Disease Control and Prevention (CDC) suggest that the inciresistance. Indeed, the prevalence of pneumonia among adults with respiratory symptoms suggesting pneumonitis ranges from dence of Legionnaires' disease is highest in the northeastern United States and states in the Great Lakes area [30] ; however, only 3% in a general outpatient setting to 28% in an emergency department [36, 37] . The Panel recommends that a chest radiodifferences in ascertainment of disease may be a contributing factor. The incidence of pneumonias due to pathogens that are graph be obtained for the routine evaluation of patients who are likely to have pneumonia (A, II). environmentally related would be expected to vary along with
Decision to Hospitalize
clues that may lead to diagnostic considerations are listed in table 6. Certain findings have historically been identified as From the standpoint of cost, the most important decision clues to specific causes of pneumonia. Acute onset, single shakconcerning the treatment of patients with CAP is whether to ing chill (rigor), and pleurisy are common features of S. pneutreat such patients as outpatients or in the hospital. A general moniae pneumonia. Hyponatremia, and possibly markedly eleconsensus is that Ç75% of patients can be appropriately treated vated temperature (ú103ЊF) and headache, may be suggestive as outpatients. Indications for admission have been summarized of legionella infection. A prodromal fever and myalgia folabove with use of a constellation of clinical observations (tables lowed by pulmonary edema and hypotension are characteristic 1 and 2) [9, 14, 15] combined with social and other factors of the hantavirus pulmonary syndrome. Underlying COPD is [21] . Laboratory studies that are helpful for determining the more often seen in patients with bacterial pneumonia, and the severity of infection and the need for hospitalization include presence of putrid sputum suggests anaerobic infection. While selected blood chemistries (i.e., glucose, blood urea nitrogen, many studies of CAP have found that clinical features often and serum sodium levels) and pulse oximetry or arterial blood cannot be used to distinguish etiologic agents [22, 39, . PCR for detection of Mycobacterium tuberculosis is the only PCR assay for detection of a sents a difference with the ATS guidelines [1] . Arguments against microbiological studies include the low yield cited in respiratory tract pathogen that has been cleared by the U.S. Food and Drug Administration (FDA), but this assay is recommany reports [7, 22 -24] and the failure to document benefit in terms of cost or outcome. A concern of the Panel is our mended for use only with specimens showing acid-fast bacilli on direct smear. Diagnostic procedures that provide identificaperception that the quality of microbiological technology, as applied to respiratory secretions, has deteriorated substantially tion of a specific etiology within 24 -72 hours can still be useful for guiding continued therapy. compared with that of an earlier era [10] . Furthermore, it is our perception that regulations from the Clinical Laboratory
The etiologic diagnosis can be useful for both prognostic and therapeutic purposes. As noted previously, several studies Improvement Act contributed to this decline despite justification that was based on quality improvement. With regard to have shown that the mortality associated with CAP among hospitalized patients is the same for those with and without the failure to document benefit, the Panel agrees that no studies have clearly demonstrated the cost-effectiveness or other adetiologic diagnoses [51 -55] . This finding has been used subsequently to justify empirical treatment with no attempt to idenvantages of attempts to identify etiologic pathogens, but conclusions on this point are not possible because there are no tify a pulmonary pathogen. The problem with this conclusion is that there have been no studies specifically designed to test studies specifically designed to address this issue. Our rationale for preserving microbiological and immunologic testing is sumthe hypothesis. Instead, the conclusion is based on retrospective analyses of cases with and without etiologic diagnoses [42] . marized in table 5. The desire to identify the etiologic agent is heightened by concern for empirical selection of drugs due
Other outcomes that are also of interest and that have not been assessed are length-of-stay, cost, resource utilization, and to increasing microbial resistance to drugs, unnecessary costs, and avoidable side effects. In addition, the work of prior invesmorbidity. Some studies, though uncontrolled, have suggested the benefit of these diagnostic studies [56 -59] . For example, tigators to identify pulmonary pathogens provides the information considered essential to write guidelines.
Gleckman et al. [58] reported that an early diagnosis based on sputum gram-stain results correlated with a more rapid resolu-A detailed history can be important in the evaluation of CAP and may be helpful in making a diagnosis. Epidemiological tion of a patient's fever after initiation of antimicrobial therapy.
/ 9c4a$$ap63 03-10-98 14:28:22 cidas UC: CID Table 4 . Diagnostic studies for evaluation of community-acquired pneumonia.
• Baseline assessment Chest radiography to substantiate diagnosis of pneumonia, detect associated lung diseases, as baseline to assess response, to predict pathogen, and to assess severity NOTE. BAL Å bronchoalveolar lavage; PMNs Å polymorphonuclear neutrophils. * Should be a deep-cough specimen obtained before antibiotic therapy. Gram stain should be interpreted by trained personnel, and culture should be done only if specimen is adequate by cytological criteria, except for Legionella and mycobacteria. Consider diagnostic studies for endemic fungi and mycobacteria when clinical features suggest these diagnoses. For hospitalized patients with severe pneumonia or clinical features suggesting Legionnaires' disease, perform culture and urine antigen assay. The inability to obtain specimens for diagnostic studies should not delay antibiotic treatment of acutely ill patients.
† Serological tests would include those for M. pneumoniae, Legionella pneumophila, C. pneumoniae, or other organisms (i.e., viruses, Chlamydia psittaci, or Coxiella burnetii), depending on the circumstances.
An additional study by Torres et al. [59] showed that inadequate more cost-effective use of antimicrobial agents. On the other hand, the utility of diagnostic studies for CAP of less severity antibiotic treatment was clearly related to poor outcomes, and this finding suggests that the establishment of an etiologic diag-(not requiring hospitalization) is unclear. More studies are needed to verify the significance of diagnostic studies in such nosis is important.
It is our consensus that establishment of an etiologic diagnocases.
Confidence in the accuracy of the diagnosis depends on the sis has value for patients requiring hospitalization (B, II). The goal is a specific diagnosis allowing for more precise and often pathogen and on the diagnostic test as follows:
/ 9c4a$$ap63 03-10-98 14:28:22 cidas UC: CID by using low-power-field (LPF) microscopy; some authorities furthermore, a negative specimen may enhance the probability of consider õ25 SECs per LPF to be an appropriate minimal an atypical agent (which may influence the antimicrobial treatment decision), and a good-quality specimen that does not show or criterion based on correlation of culture of screened specimens
yield Staphylococcus aureus or gram-negative bacilli provides good evidence that these organisms are not present. This information may prove useful for patients who do not respond to Routine cultures of expectorated sputum are neither sensitive 4 . Cytological screening should be done under low-power nor specific when they are performed by using the common magnifications (1100) to determine the cellular composition.
bacteriologic methods available in many laboratories. Problems
Criteria for culture are variable: the ''classic study'' required include antecedent antibiotic exposure, poor-quality specimens, amine culture plates, and rapid plating after specimen collection. The yield of S. pneumoniae is substantially higher in cultures compared with transtracheal aspiration (A, I) [48, 49] . Mycobacteria and Legionella species are exceptions, since cytologiof transtracheal aspirates [66 -69] and transthoracic needle aspirates [67, 70] and in quantitative cultures of BAL aspirates cal criteria may give misleading results. Gram stains should be performed rapidly to reduce unnecessary delays in therapy. [71] . The relatively low yield of S. pneumoniae from expectorated sputum is at least partially explained by the lack of strict Cultures should also be performed rapidly to improve accuracy; delays from the time of specimen collection to incubation that adherence to quality assurance for expeditious transport and processing of specimens. Prior antibiotic therapy significantly exceed 2 -5 hours may be associated with deceptive results [47] . Interpretations of expectorated sputum culture results reduces the yield of common respiratory pathogens from cultures of respiratory tract specimens from any source, and prior should include clinical correlations and semiquantitative results. In office practices, it may not be realistic to prepare a therapy is often associated with false-positive cultures for upper airway contaminants such as gram-negative bacilli or S. aureus gram stain in a timely manner to guide antibiotic decisions, but a slide may be prepared, air dried, and heat fixed for subsequent [43, 67] . The concern over false-negative cultures after antibiotic therapy is particularly great with respect to common fastidinterpretation (C, III).
The limitations of these recommendations are that many ious pathogens such as S. pneumoniae or H. influenzae. (3) Induced sputum: This method of obtaining sputum is patients cannot produce good specimens and have often received antimicrobial agents before evaluation, and the results generally recommended for detection of P. carinii and for detection of M. tuberculosis in patients who cannot provide with many specimens are inconclusive. Nevertheless, the results of multiple studies support the utility of routine sputum expectorated sputum samples [67] . The utility of this method in the detection of other pulmonary pathogens is poorly estabbacteriology, with recognition of lancet-shaped gram-positive diplococci suggesting infection due to S. pneumoniae. Most lished.
(4) Serological studies: These tests are usually not helpful studies have shown that the sensitivity of sputum gram stains for patients with pneumococcal pneumonia is 50% -60% and in the initial evaluation of patients with CAP (C, III), but they may provide data that are useful for epidemiological surveilthat the specificity is ú80% [41, 44 -46, 58] . In addition, Gleckman et al. [55] found that by using blood culture isolates lance. The presence of cold agglutinins at a titer of §1:64 supports the diagnosis of M. pneumoniae infection with a sensias a standard of reference and by using selectively defined criteria for the validity of sputum specimens, the sensitivity of tivity of 30% -60%, but agglutination assays have poor specificity. Up to 1 week is required for IgM antibodies to a ''positive'' gram stain was 85% and physicians could have / 9c4a$$ap63 03-10-98 14:28:22 cidas UC: CID 
M. pneumoniae to reach diagnostic titers, and these titers persist
The relative merits of various tests for C. pneumoniae (microimmunofluorescence serology, PCR, or culture) [72] have for 2 -12 months. The serological responses to Chlamydia and Legionella take longer; therefore testing of acute-phase sera is been debated, and few diagnostic microbiology laboratories offer any of these tests. In primary infection due to C. pneumonnot usually helpful when therapeutic decisions must be made.
iae, IgM antibodies may take up to 3 weeks to appear, and IgG antibodies may take up to 8 weeks to appear [73] . Therefore, the absence of detectable antibodies (even IgM) several weeks TTA was previously used to obtain uncondisease retrospectively is primarily for epidemiological information. The above data indicate that there are no commonly taminated lower respiratory secretions that were valid for culture of anaerobic organisms and common aerobic pathogens available serological tests that can be used to accurately guide therapy for acute infections caused by M. pneumoniae, C. pneu- [43, 67] . This procedure is now infrequently performed because of concern for adverse effects and lack of personnel skilled in moniae, or Legionella species (D, III).
(5) Antigen detection: Antigen detection methods for identithe technique. A consequence of the reduced use of TTA is the lack of any method for detecting anaerobic bacteria in the fying microorganisms in sputum and in other fluids have been studied for ú70 years with a variety of techniques: counterimlung when empyema or bacteremia are absent. The utility of fiberoptic bronchoscopy varies depending on munoelectrophoresis, latex agglutination, immunofluorescence, and EIA. While the use of these techniques for detecting bactethe pathogen and the technique. Because aspirates obtained from the inner channel of the bronchoscope are subject to rial agents (i.e., S. pneumoniae) has been favored in many European centers, their use has been less acceptable in North contamination by the upper airway flora, they should not be cultured anaerobically, and they have the same diagnostic limiAmerican laboratories. Cost, time requirements, and relative lack of sensitivity and specificity (depending upon the method) tations as expectorated sputum [67, 76] . For recovery of common bacterial pathogens, quantitative culture of BAL fluid or are potential limitations. The Quellung test for S. pneumoniae is an exception, with the proviso that there is adequate expertise. a protected brush catheter specimen is considered superior [77, 78] . The techniques for collection, transport, and processing Rapid, commercially available EIAs are available for the detection of influenza virus; respiratory syncytial virus (RSV); adeof specimens for quantitative culture have been published [67, 77, 78] . Bronchoscopy is impractical for routine use because novirus; and parainfluenza viruses 1, 2, and 3. The sensitivities of these tests are ú80%.
it is expensive, requires technical expertise, and may be difficult to perform in a timely manner. Some authorities favor its use Urine antigen tests have been shown to be sensitive and specific for detecting Legionella pneumophila serogroup 1, in patients with fulminant clinical courses who require admission to the intensive care unit or have complex pneumonias which accounts for Ç70% of reported cases of Legionnaires' disease in the United States [30] ; other possible advantages of that are unresponsive to antimicrobial therapy [11, 67, 71, 79] . Bronchoscopy is especially useful for detecting selected pathothese tests are the technical ease of performing them and the validity of results after several days of effective antibiotic treatgens such as P. carinii, Mycobacterium species, and cytomegalovirus. Most investigators view this procedure as relatively ment. DFA staining of respiratory secretions is technically demanding, yields optimal results with L. pneumophila, and has risk-free for selected patients, especially those who are compromised [67] . For detection of AFB, specimens obtained by bronpoor sensitivity and specificity when not performed by experts using only certain antibodies. Culture and urine antigen tests choscopy offer no clear advantage over expectorated sputum or induced sputum, but bronchoscopy is advocated for patients have sensitivities of 50% -60% and ú95% specificity. A negative laboratory test does not exclude Legionnaires' disease, who are suspected of having mycobacterial infection and who cannot produce sputum, and it adds to the total yield along particularly if it is caused by organisms other than L. pneumophila serogroup 1, but a positive culture or urine antigen with induced sputum [80] . PLNA has been used primarily for cytological evaluation assay is virtually diagnostic. To detect Legionnaires' disease, the Panel recommends urine antigen assays and sputum culture of suspected neoplasms or for the investigation of pulmonary infiltrates in immunocompromised patients. The use of this on selective and nonselective media with specimen decontamination before plating (A, II).
technique for diagnosing the etiology of CAP has been limited / 9c4a$$ap63 03-10-98 14:28:22 cidas UC: CID in the past because of potential complications, especially bleedIn the United States, nonsusceptibility to penicillin has increased markedly during the last decade [33, 82, 83] . The ing and pneumothorax. The more recent introduction of thinner needles has reduced the frequency of complications. The diagprevalence of resistance varies sharply by geographic region and can change rapidly over time [83] ; a survey in 1994 of nostic yield ranges from Ç40% to 80% [67, 70] . This technique is often preferably performed under fluoroscopic guidance.
1,527 isolates from 30 centers showed that 24% of pneumococci had reduced susceptibility to penicillin, including 10% Contraindications include the presence of bullous pulmonary disease in the area requiring aspiration, a suspected vascular that had high-level resistance (MIC, §2 mg/mL) [83] . The MICs for most strains with high-level resistance are 2 -4 mg/ lesion, a bleeding disorder, inability to cooperate, and intractable cough (a relative contraindication). Limitations of PLNA mL. Strains with reduced susceptibility to penicillin are often resistant to other b-lactams, trimethoprim-sulfamethoxazole, include the small specimen volume obtained and the possibility of improper needle placement, leading to false-negative results macrolides, and other antibiotics. In some communities, a smaller, but still substantial percentage of isolates are resistant [70] .
The Panel recommends that only blood cultures and gram to multiple drugs commonly used to treat CAP. A survey of 720 isolates of S. pneumoniae from 11 states staining and culture of expectorated sputum be considered the routine microbiological studies for patients hospitalized with in 1993 -1994 showed that 89% of 128 strains that were nonsusceptible to penicillin were of serotypes included in the 23-CAP. TTA, transthoracic needle aspiration, and bronchoscopy should be reserved for selected patients and then used only valent vaccine [33] . Members of the Panel are not aware of clinical failures of penicillin treatment for pneumococcal pneuwith appropriate expertise (B, III).
monia that have been ascribed to in vitro resistance, and one report has shown a lack of clinical correlation with in vitro Diagnostic Approach -Recommendations susceptibility test results for patients treated with penicillin or cephalosporins [84] . For strains that show intermediate resis- Table 4 lists diagnostic studies recommended for hospitaltance (MIC, 0.1 -1.0 mg/mL), parenteral penicillin or oral ized patients, according to the severity of illness (B, II). amoxicillin continue to be considered appropriate therapies, although oral cephalosporins and macrolides may be inadeSpecial Considerations quate for these strains. The same concern regarding lack of correlation between in vitro and in vivo results applies to treatPneumococcal Pneumonia ment of infections due to strains with high-level resistance (MIC, §2 mg/mL), but in this setting we advocate alternative S. pneumoniae is among the leading infectious causes of illness and death worldwide for young children, persons who agents that are more predictably active or have demonstrated in vitro activity. have underlying chronic systemic conditions, and the elderly. A meta-analysis of 122 reports of CAP that were published in Initial treatment for pneumococcal pneumonia is empirical because rapid, sensitive, and specific susceptibility tests are the English-language literature from 1966 through 1995 showed that S. pneumoniae accounted for 66% of ú7,000 cases not available. Excessive use of antimicrobial drugs and use of inappropriate empirical or prophylactic agents contribute to in which an etiologic diagnosis was made and that it also accounted for Ç66% of lethal pneumonias [8] . It has been the spread of drug-resistant S. pneumoniae by providing drugresistant organisms a selective advantage. Optimally, the choice estimated that 500,000 cases of pneumococcal pneumonia occur annually in the United States. A vaccine for the most comof antimicrobial drug to treat pneumococcal pneumonia should be guided by local or regional prevalence of drug-resistant mon serotypes of S. pneumoniae is available, and the Advisory Committee on Immunization Practices recommends that the S. pneumoniae. Since the prevalence of resistance to penicillin and other drugs in most communities is currently unknown, vaccine be administered to all persons §65 years of age and to younger persons who have underlying medical conditions many states are implementing surveillance for drug-resistant pneumococcal infections, so that community-specific data may associated with an increased risk for pneumococcal disease and its complications [81] . become available soon. In accordance with the standards of the National Committee Until recently in the United States, S. pneumoniae was nearly uniformly susceptible to penicillin; this circumstance allowed for Clinical Laboratory Standards, all isolates of S. pneumoniae from usually sterile sites (e.g., blood or CSF) should be tested clinicians to treat patients with severe pneumococcal infection with penicillin G alone, without testing for drug susceptibility.
for penicillin resistance (B, III). A 1-mg oxacillin disk can be used to screen for penicillin nonsusceptibility (ú99% sensitivResistance of S. pneumoniae to penicillin and to other antimicrobial drugs, first noted in Australia and Papua New Guinea ity and 80% specificity). When isolates are found to be nonsusceptible by use of the oxacillin disk method, the MICs of in the 1960s, spread to South Africa in the 1970s and subsequently to many countries in Europe, Africa, and Asia in the penicillin, cefotaxime or ceftriaxone, tetracyclines, chloramphenicol, vancomycin, fluoroquinolones, and other drugs for 1980s.
/ 9c4a$$ap63
03-10-98 14:28:22 cidas UC: CID such isolates should be determined. Some authorities believe segment (the lower lobes are dependent in the upright position, and the superior segments of the lower lobes and posterior that use of the oxacillin disk for screening is no longer justified because of the high rate of penicillin resistance and the resulting segments of the upper lobes are dependent in the recumbent position). Aspiration pneumonia is the presumed cause of day of delay in reporting results. Reliable methods for MIC testing include broth microdilution, antimicrobial gradient nearly all cases of anaerobic pulmonary infections. strips (Etest; AB BIODISK, Solna, Sweden), and agar dilution. As of this writing, automated tests are unacceptably insensitive for detecting drug resistance and should not be used for pneuAnaerobic Bacterial Infections mococcal drug susceptibility testing.
Because the diagnosis of pneumococcal disease is based on The frequency of anaerobic infection among patients with the isolation of S. pneumoniae from respiratory secretions more CAP is not known because the methods required to obtain frequently than from blood, members of the IDSA Panel recomvalid, uncontaminated specimens for meaningful anaerobic culmend that respiratory isolates be subjected to the same antimiture are rarely used. The usual specimens are transtracheal crobial susceptibility testing as described above for blood and aspirates, pleural fluid, transthoracic needle aspirates, and un-CSF isolates when S. pneumoniae is clinically suspected to be contaminated specimens from sites of metastasis [67, 88] ; limthe cause of pneumonia (B, III). Since the results of antimicroited experience suggests that quantitative cultures of protected bial susceptibility testing will typically not be available for 2 -brush or BAL specimens collected at bronchoscopy may be 3 days after specimens have been collected, the results of acceptable [67, 77, 78, 88, 89] . The results of prior studies susceptibility testing should be used to narrow the choice for suggest that anaerobic bacteria are the most common etiologic antimicrobial treatment when possible by eliminating broadagents of lung abscess and aspiration pneumonia, and these spectrum and multiple drugs that may have initially been adbacteria are relatively common isolates in cases of empyema ministered empirically. It should be emphasized again that the infection include a predisposition to aspiration, infection of the mg/mL). For strains with intermediate susceptibility (MIC, 0.1 -gingival crevice (gingivitis), putrid discharge, necrosis of tissue 1 mg/mL), parenteral penicillin/amoxicillin or alternative with abscess formation or a bronchopulmonary fistula, infection agents are preferred; for strains with high-level penicillin resiscomplicating airway obstruction, chronic course, and infection tance (MIC, §2 mg/mL), alternative agents such as vancomycin in a dependent pulmonary segment [87] . Some studies have or fluoroquinolones or other agents that are active in vitro are suggested that anaerobes may also account for a substantial preferred. Strains that are nonsusceptible to penicillin are often number of cases of CAP that do not have these characteristic resistant to macrolides and oral cephalosporins; thus these features [77, 91] . agents must be used with caution when selected empirically.
The only comparative therapeutic trials for anaerobic lung infections have been conducted in patients with lung abscess, Aspiration Pneumonia and these trials have shown that clindamycin is superior to iv penicillin [92, 93] . The use of metronidazole as a single agent Aspiration pneumonia is broadly defined as the pulmonary has resulted in a high treatment failure rate, presumably because sequela of the entry of material from the stomach or upper of the role played by aerobic and microaerophilic streptococci. respiratory tract into the lower airways. The term generally
Other regimens that appear effective are metronidazole plus peniapplies to large-volume aspiration. There are at least three cillin and amoxicillin/clavulanate (A, I) [94] . Antibiotics that distinctive forms of aspiration pneumonia [85] , according to are virtually always active against anaerobes in vitro include the nature of the inoculum, the clinical presentation, and manimipenem, meropenem, chloramphenicol, and any combination agement guidelines: toxic injury of the lung (such as gastric of a b-lactam-b-lactamase inhibitor. Macrolides, cephalospoacid aspiration or Mendelson's syndrome), obstruction (foreign rins, and doxycycline show variable activity; trimethoprimbody or fluids), or infection (table 10). These syndromes are sulfamethoxazole, aminoglycosides, and the currently available reviewed elsewhere [86, 87] . Most studies have shown that fluoroquinolones other than trovafloxacin are not active against 5% -10% of patients hospitalized with CAP are suspected of most anaerobes. having aspirated, although the criteria for this diagnosis are
The Panel recommends clindamycin as the preferred drug for often not provided. In general, the diagnosis should be sustreating pulmonary infections when anaerobic bacteria are estabpected for patients who have a predisposing cause for aspiration lished or suspected as the cause; alternative options are metroni-(usually compromised consciousness or dysphagia) and radiographic evidence of involvement of a dependent pulmonary dazole plus penicillin and amoxicillin/clavulanate (B, I).
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97]. The clinical spectrum of CAP ranges from asymptomatic infection to life-threatening pneumonia; however, the majority
Legionella species are implicated in 2% -6% of CAP cases in most hospital-based series; some groups report higher rates of cases of pneumonia due to C. pneumoniae are relatively mild and are associated with low mortality [95, 96] . C. pneumoniae that presumably reflect local epidemiology and/or superior laboratory techniques [7, 22 -24, 100] . Risk is related to exposure, pneumonia may present as sore throat, hoarseness, and headache as important nonpneumonic symptoms; other findings inincreasing age, smoking, and compromised cell-mediated immunity such as that in transplant recipients [30] . Although rare clude sinusitis, reactive airways disease, and empyema. Reinfection is common, and hospitalization due to pneumonia in immunocompetent adults of õ30 years of age, legionellosis can be a major cause of lethal pneumonia, with mortality rates caused by C. pneumoniae is usually required for older patients who have reinfection in which comorbidities undoubtedly play of 5% -25% among immunocompetent hosts and substantially higher rates among immunosuppressed hosts [30, 100] . Diaga significant role in the clinical course. C. pneumoniae is often found in association with other pathogens, particularly S. pneunostic testing is arbitrary in terms of indications and choice of tests (table 7) . Tests commonly cost $50 to $100 each, and moniae, and the associated pathogen appears to influence the clinical course of the pneumonia [95] .
therefore, routine testing of hospitalized patients is not usually advocated. Infection can be suspected on the basis of culture of C. pneumoniae, DNA detection, PCR, and serology (most speMajor indications for testing hospitalized patients include the following: severe illness requiring admission to the intencifically, by detection of microimmunofluorescent antibodies) [47, 72, 95 -97] . However, cell culture is not routinely available sive care unit, lack of any other likely etiology except Legionella species (i.e., a gram stain is negative), pneumonia in a except in research laboratories; PCR technology is not standardized, the reagents for PCR are not FDA cleared, and serolcompromised host, evidence that Legionella species are endemic or epidemic in the area, lack of response to b-lactam ogy is problematic because it is nonspecific [47, 98] . The preferred diagnostic test is assay of acute and convalescent antibiotics, or clinical features suggesting Legionella as the cause (C, III) [74] . Epidemiological risk factors for Legionspecimens to detect a fourfold increase in antibody titers, with supporting evidence based on PCR or culture results. With the naires' disease include recent travel with an overnight stay outside the home, recent repair of domestic plumbing, renal or current limitations in diagnostic testing, most laboratories will not be able to confirm or exclude a diagnosis of C. pneumoniae hepatic failure, diabetes, or systemic malignancy [30] . Some investigators believe that the following clinical features suggest pneumonia in a timely fashion; therefore, treatment must be empirical (A, II chest radiography. Common symptoms in cases of pneumonia include a prodromal period with fever, chills, headache, and This frequently lethal systemic disease of previously healthy young adults was originally recognized in May 1993. At least sore throat; these symptoms are followed by a cough that is dry or productive of mucoid sputum [31, 107] . The cough is five viruses in the Hantavirus genus are implicated, the most common of which is Sin Nombre (SN) virus [105] . The primary frequently most severe at night and may persist for 3 -4 weeks. A possible clue to this diagnosis is a history of contact with a host for SN virus is the deer mouse Peromyscus maniculatus, which apparently remains healthy but sheds the virus in urine, person with a similar condition characterized by a long incubation period. Extrapulmonary manifestations may include cold stool, and saliva. The usual mechanism of transmission is by aerosolization. Cases of HPS have been reported in nearly hemagglutination and hemolytic anemia, nausea and vomiting, myocarditis, rash, and diverse neurological syndromes. every region of the United States, but most cases have been found in the Four Corners area (New Mexico, Arizona, Utah, Laboratory tests to confirm infection due to M. pneumoniae include culture for Mycoplasma, serological tests, and PCR [32, and Colorado). The median age of the patients with the first hundred cases in the United States was 35 years, and the overall 50, 72]. Fastidious growth requirements and long incubation periods limit the utility of culture, and most laboratories do case fatality rate was 52% [106] .
Common features of the prodromal phase include fever, not offer this test. Titers of IgM and IgG antibodies become elevated in most cases, but the response is often delayed so chills, myalgias, headache, nausea, vomiting, and/or diarrhea. A cough is common but is not a prominent early feature. Initial that the utility of these tests for early detection is also limited. Some authorities consider PCR to be particularly promising symptoms resemble those of other common viral infections. Characteristic features often become evident after the 3 -6 day
[50]. Current problems with amplification techniques include great variability due to differences in methods of sample collecprodrome and include characteristic laboratory changes, a chest radiograph showing capillary leakage (adult respiratory distress tion, sample preparation, and amplification procedure; there are / 9c4a$$ap63 03-10-98 14:28:22 cidas UC: CID also no FDA-cleared reagents with which to perform PCR for [108] . The diagnostic yield with induced sputum averages 60% but varies greatly, depending on quality control [109] . The Mycoplasma detection. Cold agglutinin titers of §1:64 support the diagnosis, and the cold agglutinin response correlates with yield with bronchoscopy exceeds 95%. The disease is uniformly fatal if not treated. Trimethoprimthe severity of pulmonary symptoms; however, the test lacks specificity.
sulfamethoxazole, dapsone/trimethoprim, and clindamycin/primaquine appear to be equally effective for treatment of patients It has been suggested that a single CF antibody titer of §1:64, combined with a cold agglutinin titer of §1:64, is who have moderately severe disease [110] . No treatment currently recommended by these or other guidelines for the immustrongly supportive of this diagnosis [31, 32] . The antibody response usually develops 7 -10 days after the onset of sympnocompetent host with pneumonia is likely to be effective for PCP. (This statement applies to trimethoprim-sulfamethoxazole toms and shows peak levels at Ç3 weeks. Changes on chest radiographs are nonspecific; the most common change is a as well because of differences in dosage). The mortality rate among treated patients who are hospitalized has usually been unilateral infiltrate, but one-third of patients have bilateral changes.
reported to be 15% -20%. Members of the Panel have concluded that there is no diagnostic test that will reliably and rapidly detect M. pneumoniae infection and that is readily available to most laboratories.
Influenza
Thus, therapy must usually be empirical (B, II). The Panel recommends treatment with tetracycline or a macrolide for
In terms of morbidity and mortality, influenza is clearly the most serious viral airway infection of adults. Seasonal epidemmost cases; an alternative is the fluoroquinolones (B, III). Treatment should be given for 2 -3 weeks to reduce the risk of ics are commonly associated with §20,000 deaths in the United States that are ascribed to this infection and its complications, relapse. The role of antibiotic therapy for extrapulmonary manifestations has not been established.
primarily bacterial superinfections. The great pandemics of influenza in the past century were the ''Spanish flu'' of 1918 that was responsible for ú20 million deaths worldwide, the
Pneumocystis carinii Pneumonia (PCP)
Asian influenza of 1957, and the Hong Kong influenza of 1968. Analysis of historical records, molecular epidemiological find-PCP is not included in the guidelines for management of CAP in immunocompetent hosts because PCP is seen excluings, and seroarcheology suggests that there will be another influenza pandemic among humans, but the time has not been sively in patients with defective cell-mediated immunity. Nevertheless, this is a relatively common and important form of predicted [111] . The majority of patients who die during annual influenza pneumonia, especially in patients with HIV infection who may not have had the underlying defect in host defenses recognized epidemics are ú65 years of age, a disproportionate number of whom are residents of chronic care facilities. The most common at the time of presentation. One recent study of 385 consecutive hospitalizations for CAP in an urban hospital showed that 46% cause of bacterial superinfection is S. pneumoniae and, to a lesser extent, S. aureus [112] . In general, influenza A is more of patients had HIV infection and that 19% of these patients were unaware of their HIV status at the time of admission [24] .
severe and shows greater antigenic heterogeneity than influenza B. Treatment with amantadine or rimantidine appears to reduce The point to emphasize is that PCP is the most common initial AIDS-defining diagnosis and should be suspected in selected symptoms in patients with influenza A, but it is not clear that this treatment reduces mortality rates or complications such as patients, even in the absence of known immunodeficiency.
Characteristic clinical features of PCP include a nonproducbacterial superinfections [113] . Annual administration of vaccine provides the most effective tive cough, fever, and dyspnea that evolve over a period of weeks. The average patient complains of pulmonary symptoms prophylaxis, usually with an efficacy of 60% -70% for prevention of transmission. Efficacy for prevention is reduced in elthat have been present for Ç4 weeks at the time of initial presentation; this relatively slow progression of disease is a derly residents of chronic care facilities, but the effectiveness in preventing death is often reported to be 70% -80% in this characteristic feature that distinguishes PCP from common forms of bacterial pneumonia in patients with AIDS. The usual population, depending to some extent on the match between the epidemic strain and the constituents of the vaccine [114] . associated laboratory features include lymphopenia (total lymphocyte count, õ1,000/mL), CD4 lymphopenia (CD4 lympho-A recent provocative report suggests that vaccination of health care providers in chronic care facilities is as important or more cyte count, õ200/mL in ú95% of patients), arterial hypoxemia, and a chest radiograph that shows bilateral interstitial important than vaccination of the patients [115] . These data emphasize the importance of vaccine strategies that target the infiltrates with a highly characteristic ''ground-glass'' appearance. Up to 30% of patients have unremarkable chest radiopopulations at greatest risk, including persons aged 65 years or older, patients with cardiopulmonary disease, and residents graphs, making this illness the only relatively common form of pneumonia associated with false-negative chest radiographs of nursing homes and their care providers (A, I).
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Rational use of the microbiology laboratory.
Patients who are candidates for hospitalization with acute pneumonia The traditional definition of pleural empyema is pus in the should have blood cultures performed and a physician-propleural space. More recently, investigators have performed cured expectorated sputum specimen obtained before antipleural fluid analyses; a pleural effusion with a pH of õ7.2 microbials are administered unless these procedures would usually indicates a need for drainage [116] . The frequency of delay initiation of treatment (B, II). Consensus as to the this complication among patients with CAP that is sufficiently need for obtaining microbiological diagnoses for outpatients severe to require hospitalization is reported to be 1% -2% [8] .
is lacking, although it is desirable to prepare an air-dried, The incidence of empyema has decreased substantially from heat-fixed slide of sputum for subsequent gram staining the preantibiotic era, when S. pneumoniae accounted for about before antimicrobial treatment is started. Investigation for two-thirds of cases, and the bacteriology has changed as well.
selected microbial pathogens such as Legionella and myco-A meta-analysis of 1,289 cases of empyema reported from bacteria will depend on clinical features. 1970 to 1995 showed that S. pneumoniae now accounts for only
2. An attempt should be made to administer pathogen-directed 5% -10% of cases; the majority involve anaerobic bacteria, antimicrobial therapy to hospitalized patients (C, III) (table S. aureus, and/or gram-negative bacilli [117] . Many cases of 11). This decision should be made when relevant informaempyema are mixed infections, and many are culture negative, tion becomes available, and its strength is greatest in cases findings that suggest the use of inadequate culture techniques where an established etiologic agent has been identified or the impact of prior antibiotic treatment. according to the criteria described above. When necessary, Most studies of CAP show that up to 57% of patients with empirical agents should be chosen that are directed against CAP have pleural effusions identified on routine chest radiothe pathogens that are most common and treatable according graphs [118] . Empyema is infrequent in these patients, but it is to the setting (table 12) . Antibiotic regimens selected empirimportant to recognize the condition because of its implications ically should be changed in light of culture and in vitro regarding the need for adequate drainage, a critical component susceptibility test results when this information becomes of effective management. Some authorities recommend thoraavailable, on the assumption that clinical and microbiologicentesis for any parapneumonic effusion that measures ú10 cal correlations support this tactic. mm on a lateral decubitus radiograph [118] . Standard tests to 3. Antimicrobial treatment should be initiated promptly after be performed on pleural fluid include appropriate stains and the diagnosis of pneumonia is established on the basis of culture for aerobic and anaerobic bacteria; measurement of pH, radiographic findings and gram stain results are available the lactate dehydrogenase level, and the leukocyte count; and to facilitate antimicrobial selection. For patients requiring determination of the differential. Particularly important is the hospitalization for acute pneumonia, it is important to initipH, which requires the same handling as a specimen for an ate therapy in a timely fashion; there is at least one analysis arterial blood gas determination: fluid is obtained anaerobically, of 14,000 patients that showed that a delay from the time placed on ice, and the pH is measured in a radiometer system. of admission to initiation of antibiotic treatment exceeding Pus in the pleural space requires drainage; a positive culture 8 hours was associated with an increase in mortality (B, II) or a pH of õ7.2 usually will require drainage. Neither the [119] . Antibiotic treatment should not be withheld from lactate dehydrogenase or glucose levels are as sensitive as pH acutely ill patients because of delays in obtaining approfor this prediction.
priate specimens or the results of gram stains and cultures. Drainage is not necessary for uncomplicated parapneumonic 4. Decisions regarding hospitalization should be based on effusions, e.g., free-flowing fluid with a pH of ú7.3. Parapneuprognostic criteria, as summarized in tables 1 and 2 (A, I). monic effusions for which gram stains or cultures are positive
In addition, this decision will be influenced by other factors or those with a pH of õ7.2 will usually require drainage.
such as the availability of home support, probability of comPleural pus always requires drainage. The drainage technique pliance, and availability of alternative settings for supermay be by chest tube, image-guided catheters, thoracoscopy, vised care. Many patients with CAP are hospitalized for a or thoracotomy. The relative merits and indications for imageconcurrent disease process. Prior studies have shown that guided catheters, catheters with thrombolytics, and thorascopic 25% -50% of admissions for CAP are for these other considor thoracotomy decortication are not well defined.
erations that extend beyond those listed as admission criteria in table 1 [9] . Cephalosporins. These drugs generally show enhanced acimmunocompetent outpatients with CAP showed that erythromycin is cost-effective antimicrobial therapy [121] . tivity against aerobic gram-negative bacilli as one moves from first-to second-to third-generation agents. The agents in this
Management
Quinolones. The currently available agents in this class for treatment of pulmonary infections are ciprofloxacin, ofloxacin, class most active against strains of S. pneumoniae are cefotaxime and ceftriaxone [33, 82, 83] , and the clinical relevance of levofloxacin, sparfloxacin, grepafloxacin, and trovafloxacin. The latter four agents were introduced in 1997. These drugs in vitro resistance to these drugs is unclear [84] . The rank order of in vitro activity of oral cephalosporins against S. pneumoniae are active in vitro against most clinically significant aerobic gram-positive cocci, gram-negative bacilli, H. influenzae, is as follows: cefpodoxime § cefuroxime ú cefprozil § cefixime ú cefaclor Å loracarbef ú cefadroxil Å cephalexin [83] .
M. catarrhalis, Legionella species, M. pneumoniae, and C. pneumoniae. Ofloxacin, levofloxacin, sparfloxacin, grepThe clinical implications of these in vitro data are unclear, but none of these oral agents have established clinical efficacy in afloxacin, and trovafloxacin show enhanced in vitro activity against S. pneumoniae (including penicillin-resistant strains) cases involving strains of S. pneumoniae with reduced penicillin susceptibility. Most second-and third-generation cephalo- [33] , and initial clinical trials have shown good results [122, 123] , although there is limited published experience with these sporins show moderate-to-good activity against H. influenzae and M. catarrhalis; activity against S. aureus is variable; cefadrugs in patients with serious CAP or serious pneumococcal pneumonia. zolin and cefuroxime are the most active, and cefixime and ceftazidime are the least active. Cephalosporins with the best Ciprofloxacin is slightly less active in vitro, and there are anecdotal reports of clinical failures with this drug in the treatin vitro activity against anaerobic gram-negative bacilli (Prevotella and Bacteroides species) are cefoxitin, cefotetan, and cefment of pneumococcal pneumonia; some authorities believe that a dose of 750 mg twice daily would be adequate for metazole, although there are no published studies of the use of these drugs for anaerobic lung infections. Other cephalospoempirical use. Activity against S. aureus is somewhat variable because of increasing resistance; in general, S. aureus strains rins are less active in vitro against anaerobes.
Carbapenems. Meropenem and imipenem are active resistant to one fluoroquinolone are resistant to all members of the class. In terms of differences, ciprofloxacin and trovafloxaagainst a broad spectrum of aerobic and anaerobic gram-positive and gram-negative organisms including most strains of cin are the quinolones most active against P. aeruginosa, and trovafloxacin is the most active against anaerobes [123] . Exces-S. pneumoniae, most P. aeruginosa isolates, and virtually all strains of H. influenzae, M. catarrhalis, anaerobes, and methisive and inappropriate use of drugs in this group is a concern because increases in the MICs of ofloxacin (and presumably, cillin-susceptible S. aureus. Activity against penicillin-resistant S. pneumoniae is generally good.
other fluoroquinolones) for sequentially collected strains of S. pneumoniae have been observed [82] . Ciprofloxacin, ofloxMacrolides. Erythromycin has a limited spectrum of activity and is poorly tolerated because of gastrointestinal side efacin, levofloxacin, and trovafloxacin are available for intravenous administration. fects. Newer macrolides that are better tolerated but more expensive include azithromycin and clarithromycin. All three Aminoglycosides. The aminoglycosides (gentamicin, tobramycin, netilmicin, and amikacin) show a concentration-dedrugs appear to be effective in the treatment of pulmonary infections caused by M. pneumoniae, C. pneumoniae and Legipendent bactericidal effect, permitting a single daily dose regimen. These agents are active in vitro against the aerobic and onella species. Approximately 10% -15% of S. pneumoniae isolates are resistant to macrolides in vitro; this rate is substanfacultative gram-negative bacilli, including P. aeruginosa, and also exhibit activity against methicillin-susceptible S. aureus tially higher among penicillin-resistant strains [33, 82, 83] , so that caution is necessary when these agents are used empirically [124] . Aminoglycosides should not be used as single agents for treatment of gram-negative bacillary pneumonia. The poor in suspected cases of pneumococcal pneumonia. Activity against anaerobes, except for fusobacteria, is reasonably good.
clinical results may be due to low levels of drug obtainable in situ after intravenous injection and the possibility that the drug Community-acquired strains of S. aureus are usually susceptible to macrolides. Most bacteria are susceptible or resistant to is inactivated by the acidic environment present at the site of infection [125, 126] . all three macrolides, but there are some differences. Erythromycin is relatively inactive against H. influenzae. Clarithromycin
Tetracyclines. There are multiple members of this class, but the one most frequently used in clinical practice today is also has relatively limited in vitro activity against H. influenzae; however, its 14-OH metabolite augments the activity of the doxycycline because of its tolerability, good bioavailability, and low price and because of the convenience of twice-daily parent compound [120] . Of the three macrolides, azithromycin is the agent most active in vitro against Legionella species, dosing. From the point of view of respiratory tract pathogens, the tetracyclines are active in vitro against the atypical organ-H. influenzae, and M. pneumoniae, whereas clarithromycin is the most active against S. pneumoniae and C. pneumoniae. [33, 82, 83, 128, 129] .
Vancomycin. This drug is the only currently available agent bioavailability and activity are adequate (A, III).
Changing from intravenous to oral therapy is associated with with universal activity against S. pneumoniae [33, 83] . It is also active against other gram-positive organisms including a number of economic, healthcare, and social benefits. This change reduces costs of treatment and shortens length of hospimethicillin-resistant S. aureus.
Clindamycin. Clindamycin exhibits good in vitro activity tal stay. At least 13 randomized controlled trials have been conducted to address the issue of changing from parenteral to against gram-positive cocci, including most strains of S. pneumoniae (including most penicillin-resistant and most macrooral antibiotic treatment for a variety of infections including pneumonia. A review of these data [132] supports this change lide-resistant strains) and most isolates of methicillin-susceptible S. aureus [83, 130] . Many authorities consider clindamycin with the following provisos: a patient's condition should be improving clinically and the patient should be hemodynamito be the preferred drug for treatment of anaerobic pulmonary infections including aspiration pneumonia and putrid lung abcally stable, able to ingest drugs, and have a functioning gastrointestinal tract (A, I). In most cases, these conditions are met scess [87, 92, 93] . The drug is inactive against H. influenzae, atypical agents, and most erythromycin-resistant S. aureus within 3 days, and oral therapy can be given at that time.
Ideally, the parenteral drug should be given in an oral formulastrains.
Trimethoprim-sulfamethoxazole. This combination is action with adequate bioavailability; if no oral formulation is available, an oral agent with a similar spectrum of activity tive in vitro against a broad spectrum of gram-positive and gram-negative bacteria, although there is growing concern over should be selected on the basis of in vitro or predicted susceptibility patterns of the established or probable pathogen. increasing resistance, particularly among strains of S. pneumoniae and H. influenzae [33, 83] . Approximately 15% -20% of S. pneumoniae strains are resistant to trimethoprim-sulfameth-
Assessment of Response to Treatment
oxazole, and ú50% of penicillin-resistant S. pneumoniae are not susceptible to trimethoprim-sulfamethoxazole [33, 83] .
The expected response to treatment should be based on the clinical illness, pathogen, severity of illness, the host, and the This drug is active against such diverse pathogens as Nocardia asteroides, P. carinii, and Stenotrophomonas maltophilia chest radiographic findings. Subjective response is usually noted within 3 -5 days of initiating treatment. Objective param- [129, 131] .
eters include resolution of respiratory symptoms (cough or dyspnea), fever, the PO 2 level, the peripheral leukocyte count, and Length and Route of Treatment findings on serial radiographs. The most carefully documented response is time to defervescence. In young adults with pneuWe are not aware of any controlled trials that have specifically addressed the questions of how long pneumonia should mococcal pneumonia, the average duration of fever after treatment is 2.5 days; in patients with bacteremic pneumonia, it is be treated. This decision is usually based on the pathogen, response to treatment, comorbid illness, and complications. It 6 -7 days; and in elderly patients, it also appears to be longer. Patients with mycoplasma pneumonia are usually afebrile is known, for example, that relapses of C. pneumoniae infection may occur when erythromycin is given for õ3 weeks or when within 1 -2 days after treatment, and immunocompetent patients with Legionnaires' disease require an average of 5 days tetracycline is given for õ2 weeks [132, 133] . Until further data are forthcoming, it seems reasonable to treat bacterial for defervescence. In cases of bacteremic pneumonia, blood cultures usually infections such as those caused by S. pneumoniae until a patient is afebrile for 72 hours (C, III). Pneumonia caused by become negative within 24 -48 hours of treatment. The pathogen is usually suppressed in respiratory secretions within 24 -M. pneumoniae or C. pneumoniae should probably be treated for at least 2 weeks, as should Legionnaires' disease in immu-48 hours as well; the major exception is P. aeruginosa, which may persist despite appropriate treatment, and M. pneumoniae, nocompetent individuals (B, II). Azithromycin may be used for shorter courses of treatment because of its longer half-life which usually persists despite effective therapy. Follow-up cultures of blood and sputum are not indicated for patients who in tissue [133] .
As cost considerations increase and hospital bed closures respond to therapy, unless the pathogen is M. tuberculosis. The results of cultures of respiratory secretions from any source are become commonplace, there is rising interest in the use of oral therapy whenever possible. For many pathogens, there is no likely to be deceptive after antimicrobial therapy; this concern especially applies to fastidious pathogens such as S. pneumoclear advantage of intravenous therapy over oral therapy. However, for most patients admitted to the hospital, the common niae and H. influenzae, even for patients who fail to respond clinically [67] . practice is at least to begin therapy with intravenous drugs. to exclude underlying disease such as a neoplasm are advocated for selected patients who are ú40 years of age and/or are as response should be considered; examples are HIV infection, cystic fibrosis, neoplasms, recent travel, or exposures.
Incorrect diagnosis:
In cases in which infection is responsible for the clinical and radiographic findings, issues relating to the host-drug-pathogen Noninfectious illnesses that may account for the clinical and triad should be taken into account for the workup. To rule out the radiographic findings include congestive heart failure, pulmonary presence of an endobronchial lesion or foreign body, bronchoscopy embolus, atelectasis, sarcoid, neoplasms, radiation pneumonitis, and/or CT may be of help. To ensure that a sequestered focus of pulmonary drug reactions, BOOP, vasculitis, ARDS, pulmonary infection such as a lung abscess or empyema has not developed, hemorrhage, and inflammatory lung disease. thereby preventing access of the drugs to the pathogens, obtaining a computed tomographic scan of the chest may be useful. When pleural effusions are detected on chest radiographs, ultrasonogra-2. Correct diagnosis:
phy can localize the collection and provide an estimate of the volume of fluid. If a correct diagnosis has been made but a patient fails to respond, the physician should consider each of the components of Infection caused by an unsuspected organism or a resistant pathogen must always be a concern as well in nonresponding the HOST-DRUG-PATHOGEN triad. a) Host-related problem-The overall reported mortality for patients. An aggressive attempt to obtain appropriate expectorated sputum samples may allow identification of such organisms on hospitalized patients with CAP is 10%-15%; this figure includes patients with an established or likely etiologic diagnosis who are stain or culture, although the validity of such posttreatment specimens must be questioned because of the inability to culture treated with appropriate antibiotics [8] . The mortality rate for patients with bacteremic pneumococcal pneumonia caused by peni-S. pneumoniae and other fastidious pathogens and the frequent overgrowth by S. aureus and gram-negative bacilli. In selected cillin-susceptible strains of S. pneumoniae who are treated with penicillin has been consistently reported at §20% [84] . The usual cases, bronchoscopy may be necessary; the results of one study suggest that helpful information may be provided for up to 41% explanation is that the treatment has been initiated too late or / 9c4a$$ap63 03-10-98 14 
